Intrathecal tigecycline is a safe and effective treatment for central nervous system infections
Both the safety and effectiveness of intrathecal tigecycline (TGC) for treatment of infections of the central nervous system (CNS) are discussed using the clinical findings from a study of a recent patient who came to our attention, along with a literature review. Although penetration into the CNS i...
Main Authors: | Antonio Mastroianni, Valeria Vangeli, Maria Vittoria Mauro, Filippo Urso, Roberto Manfredi, Sonia Greco |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Encephalitis and Neuroinflammation Society
2023-07-01
|
Series: | Encephalitis |
Subjects: | |
Online Access: | http://www.encephalitisjournal.org/upload/pdf/encephalitis-2023-00010.pdf |
Similar Items
-
Intrathecal Injection of Tigecycline and Polymyxin B in the Treatment of Extensively Drug-Resistant Intracranial Acinetobacter baumannii Infection: A Case Report and Review of the Literature
by: Li Z, et al.
Published: (2022-03-01) -
Intrathecal or Intraventricular Tigecycline Therapy for Central Nervous System Infection Associated with Carbapenem-Resistant Klebsiella pneumoniae
by: Du N, et al.
Published: (2022-12-01) -
Successful Treatment of Isolated Central Nervous System Relapse with Intrathecal Chemotherapy in an Adolescent with Acute Promyelocytic Leukemia
by: Haerim Song, et al.
Published: (2022-10-01) -
Inadvertent intrathecal injection of labetalol
by: S Verma, et al.
Published: (2016-01-01) -
Intrathecal immunoglobin synthesis and its role in patients with neurosyphilis
by: Xiyue Huang, et al.
Published: (2022-11-01)